Revenue | ₹8,137.40Cr |
Net Profits | ₹845.81Cr |
Net Profit Margins | 10.39% |
Aurobindo Pharma Ltd’s revenue jumped 8.29% since last year same period to ₹8,137.40Cr in the Q3 2024-2025. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 2.58% jump in its revenue since last 3-months.
Aurobindo Pharma Ltd’s net profit fell -9.66% since last year same period to ₹845.81Cr in the Q3 2024-2025. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 3.48% jump in its net profits since last 3-months.
Aurobindo Pharma Ltd’s net profit margin fell -16.58% since last year same period to 10.39% in the Q3 2024-2025. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 0.87% jump in its net profit margins since last 3-months.
The revenue for Aurobindo Pharma Ltd in the Q3 results 2024 was ₹8,137.40Cr.
The net profit for Aurobindo Pharma Ltd in the Q3 results 2024 was ₹845.81Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q3 results 2024 was 10.39%.
The revenue for Aurobindo Pharma Ltd in the Q3 results 2023 was ₹7,514.30Cr.
The net profit for Aurobindo Pharma Ltd in the Q3 results 2023 was ₹936.29Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q3 results 2023 was 12.46%.